Abstract
3118 Background: Imatinib (Im) via PDGFR inhibition decreases the interstitial fluid pressure of tumor, increases cytotoxic drug uptake in preclinical studies, and thus may improve the efficacy of ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
